GlassScriptPhysician profile
Jordan Taylor Morgan
NPI 1366178956
$1,284.30
in general payments reported to CMS, 2019-2025
25 companies · $470 in 2025
The $470 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $155 · 2023: $446 · 2024: $214 · 2025: $470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,129.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $191.33 | 2023-2025 | |
| Ucb, INC. | $145.16 | 2023 | Briviact |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $125.00 | 2023 | |
| Boston Scientific Corporation | $96.73 | 2025 | Intracept Rf Probe, Intracept |
| Curonix LLC | $80.67 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Alexion Pharmaceuticals, INC. | $77.28 | 2023-2024 | Ultomiris |
| Abbvie INC. | $71.27 | 2023-2025 | |
| Amgen INC. | $66.36 | 2024 | Uplizna |
| Janssen Pharmaceuticals, INC | $57.26 | 2023 | Xarelto |
| Axsome Therapeutics, INC. | $42.15 | 2025 | Symbravo |
| Si-Bone, INC. | $37.96 | 2025 | |
| Lilly USA, LLC | $34.15 | 2022-2024 | Amyvid |
| Livanova USA, INC. | $31.09 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
| Morphosys, US INC. | $24.61 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $22.98 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $22.50 | 2022 | |
| Eisai INC. | $19.64 | 2022 | |
| Genzyme Corporation | $19.56 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.36 | 2025 | Relistor |
| Ipsen Biopharmaceuticals, INC | $19.02 | 2022 | |
| Emd Serono, INC. | $17.67 | 2023 | Bavencio |
| G1 Therapeutics, INC. | $17.55 | 2023 | Cosela |
| Mml US, INC. | $16.63 | 2025 | Reactiv8 |
| Mylan Institutional INC. | $14.84 | 2022 | |
| Seagen INC. | $13.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.